Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05529030 · ClinicalTrials.gov registry record · NA
COVID-19 Booster Readiness Survey
A NA study, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 12,036
- Enrollment target
NCT05529030 is a NA study that has completed, run by Geisinger Clinic. The registered enrollment target is 12,036 participants.
The verdict
NCT05529030, a NA study, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 12,036 participants
- Enrollment target
Study Summary
The purpose of this administrative survey is to inform health system logistics by assessing the attitudes towards towards the bivalent COVID-19 boosters held by healthcare workers (HCWs) at a large, rural health system. It will also test, prospectively, the effect on interest in the bivalent COVID-19 booster of different framing approaches in a survey question sent to employees of a large, rural health system.
Interventions
- BEHAVIORAL Salience of Omicron variant
- BEHAVIORAL Self-protection message
- BEHAVIORAL Other-protection message
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12,036 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2022-09-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05529030
The ClinicalTrials.gov registry entry for NCT05529030 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12,036 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Geisinger Clinic, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Salience of Omicron variant is the first listed.
NCT05529030 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05529030 about?
NCT05529030 is a clinical study titled "COVID-19 Booster Readiness Survey". The purpose of this administrative survey is to inform health system logistics by assessing the attitudes towards towards the bivalent COVID-19 boosters held by healthcare workers (HCWs) at a large, rural health system. It will also test, prospectively, the effect on interest in the bivalent COVID-1...
What is the current status of trial NCT05529030?
This trial is currently completed. It is a NA study. The enrollment target is 12,036 participants. The study started on 2022-09-01. Estimated completion is 2022-09-15.
What interventions are being tested in trial NCT05529030?
The interventions under investigation include: Salience of Omicron variant (BEHAVIORAL), Self-protection message (BEHAVIORAL), Other-protection message (BEHAVIORAL).
Who is sponsoring clinical trial NCT05529030?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.